Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development
- PMID: 23169510
- DOI: 10.1200/JCO.2012.44.1022
Adaptive trials in the neoadjuvant setting: a model to safely tailor care while accelerating drug development
Comment on
-
Defining the benefits of neoadjuvant chemotherapy for breast cancer.J Clin Oncol. 2012 May 20;30(15):1747-9. doi: 10.1200/JCO.2011.41.3161. Epub 2012 Apr 16. J Clin Oncol. 2012. PMID: 22508810 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical